The U.S. Food and Drug Administration is alerting horse owners and veterinarians that two lots of compounded combination drug products containing pyrimethamine and toltrazuril, used to treat the neurologic disease Equine Protozoal Myeloencephalitis (EPM), have been associated with adverse events in ten horses.
via What's New: Animal & Veterinary http://ift.tt/1nTPAxg
via What's New: Animal & Veterinary http://ift.tt/1nTPAxg
No comments:
Post a Comment